GlassScriptPhysician profile
Stephen M Voltarel
NPI 1437175452
$759.55
in general payments reported to CMS, 2019-2025
18 companies · $187 in 2025
The $187 reported for 2025 was more than what a typical Pediatrics provider received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $165 · 2020: $94.14 · 2021: $53.66 · 2023: $92.24 · 2024: $168 · 2025: $187.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $447.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $447.03 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cranial Technologies, INC | $126.15 | 2019-2025 | Doc Band |
| Merck Sharp & Dohme LLC | $106.16 | 2019-2025 | Vaxneuvance, Gardasil 9, Gardasil |
| Sanofi-Aventis U.S. LLC | $93.80 | 2023-2025 | |
| Astrazeneca Pharmaceuticals LP | $54.02 | 2023-2024 | Flumist Quadrivalent |
| Glaxosmithkline, LLC. | $48.41 | 2024-2025 | Bexsero |
| Alk-Abello, INC | $43.50 | 2024-2025 | Grastek, Odactra, Neffy |
| Shire North American Group INC | $41.28 | 2019 | |
| Tris Pharma INC | $40.65 | 2019-2020 | |
| Corium, LLC | $31.00 | 2025 | Azstarys |
| Pfizer INC. | $30.24 | 2020 | |
| Sobi, INC | $23.73 | 2024 | |
| Verrica Pharmaceuticals INC. | $20.54 | 2025 | Ycanth |
| Takeda Pharmaceuticals U.S.A., INC. | $19.45 | 2020 | |
| Ironshore Pharmaceuticals INC. | $18.16 | 2019 | |
| Seqirus USA INC | $17.57 | 2025 | Flucelvax |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kaleo, INC. | $16.56 | 2023 | Auvi-Q |
| Phadia US INC. | $14.21 | 2019 | |
| Sanofi Pasteur INC. | $14.12 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stephen Voltarel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.